Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Autor: Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik J.H. Hoogwater, Saleh A. Alqahtani, Helen L. Reeves, David J. Pinato, Emmanouil Giorgakis, Tim Meyer, Gerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R. Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Josepmaria Argemi, Bristi Basu, Leonardo da Fonseca, Juan Acevedo, Alexander R. Siebenhüner, Chiara Braconi, Brandon M. Meyers, Alessandro Granito, Margarita Sala, Carlos Rodríguez-Lope, Lorraine Blaise, Manuel Romero-Gómez, Federico Piñero, Dhanny Gomez, Vivianne Mello, Rogerio Camargo Pinheiro Alves, Alex França, Fernanda Branco, Giovanni Brandi, Gustavo Pereira, Susanna Coll, Maria Guarino, Carlos Benítez, Maria Margarita Anders, Juan C. Bandi, Mercedes Vergara, Mariona Calvo, Markus Peck-Radosavljevic, Ignacio García-Juárez, Vincenzo Cardinale, Mar Lozano, Martina Gambato, Stefano Okolicsanyi, Dalia Morales-Arraez, Alessandra Elvevi, Alberto E. Muñoz, Alberto Lué, Massimo Iavarone, Maria Reig

Publikováno v: JHEP Reports, Vol 3, Iss 3, Pp 100260- (2021)

Background & Aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening o

Externí odkaz: https://doaj.org/article/358015dbb4fa490089fab9515bd56c57

Usefulness of Indocyanine Green Plasma Disappearance Rate in Liver Donors and Recipients: A Prospective Observational Study

Autor: Sergio Cortese, José Ángel López Baena, José María Pérez Peña, Ana María Matilla, Luis Olmedilla, Álvaro Morales Taboada, María Luz Fernández Vázquez, María Fernández Martínez, José Manuel Asencio

Publikováno v: Transplantation proceedings. 54(9)

Determination of indocyanine green (ICG) plasma disappearance rate (PDR) is a simple, inexpensive, and noninvasive tool to assess liver perfusion, absorption, and elimination. Its application in the liver transplant process has not been widely incorp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db57afab021fb696e514035838f47c36
https://pubmed.ncbi.nlm.nih.gov/36270855

THE COMPLEX MANAGEMENT OF HEPATOCELLULAR CARCINOMA: A MAJOR NEED OF EXPERTISE

Autor: Ana María, Matilla, María, Varela, María, Reig

Publikováno v: Revista Española de Enfermedades Digestivas.

Hepatocellular carcinoma (HCC) is the most frequent liver primary cancer and represents the sixth malignant neoplasm and the fourth cause of cancer associated deaths worldwide. Despite improvements across the last years in therapeutic options, it is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8f35cc4aec71f32a9fc7889c18f9e3e
https://doi.org/10.17235/reed.2022.8953/2022

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Autor: Manuel Delgado, Mar Lozano, Alejandro Forner, Bruno Sangro, Alessandro Granito, Margarita Sala, Monica Ronzoni, Giuseppe Cabibbo, Frederik J H Hoogwater, José Luis Lledó, Rosanna Villani, Alessandra Elvevi, Lorenza Rimassa, Juan Acevedo, Mariona Calvo, Mercedes Vergara, Sergio Muñoz-Martínez, Jean-Charles Nault, Juan C. Bandi, Markus Peck-Radosavljevic, Brandon M. Meyers, Marco Sanduzzi-Zamparelli, Rogerio Alves, Saleh A. Alqahtani, Alberto E. Muñoz, Sonia Pascual, Alberto Lué, Josepmaria Argemi, Beatriz Minguez, Henning Wege, Giovan Giuseppe Di Costanzo, David J. Pinato, Victor Sapena, Maria Guarino, Stefano Okolicsanyi, Vivianne Mello, Martina Gambato, Susanna Coll, Carlos Benítez, Dhanny Gomez, Christoph Roderburg, Peter R. Galle, Bristi Basu, Federico Piñero, Cassia Leal, Frank Tacke, Christie Perelló, Tudor Mocan, Massimiliano Salati, Helen L. Reeves, Jörg Trojan, Vincenzo Cardinale, Mohamed El Kassas, Tom Lüdde, John Bridgewater, Mário Reis Álvares-da-Silva, Anja Lachenmayer, Giovanni Brandi, Alex Vianey Callado França, Mohamed Bouattour, Tim Meyer, Gerda Elisabeth Villadsen, M. Varela, Jordi Bruix, Dalia Morales-Arraez, Carlos Rodríguez-Lope, Christian Toso, Wacław Hołówko, Philippe Merle, Manuel Romero-Gómez, Ignacio García-Juárez, Fernanda Branco, Gonzalo Sapisochin, Chiara Braconi, Emmanouil Giorgakis, Hidenori Toyoda, Lorraine Blaise, Ana María Matilla Peña, Andrea Casadei-Gardini, Leonardo G Da Fonseca, Alexander Siebenhüner, Maria Reig, Gustavo Pereira, Massimo Iavarone, Maria Margarita Anders

Publikováno v: JHEP reports : innovation in hepatology, Vol. 3, No 3 (2021) P. 100260
Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; Sapisochin, Gonzalo; Rimassa, Lorenza; Sangro, Bruno; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Hołówko, Wacław; El Kassas, Mohamed; Mocan, Tudor; Bouattour, Mohamed; Merle, Philippe; Hoogwater, Frederik J H; Alqahtani, Saleh A; Reeves, Helen L; Pinato, David J; Giorgakis, Emmanouil; Meyer, Tim; ... (2021). Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP reports, 3(3), p. 100260. Elsevier 10.1016/j.jhepr.2021.100260
JHEP Reports, Vol 3, Iss 3, Pp 100260-(2021)
JHEP reports : innovation in hepatology, 3(3):100260. Elsevier
Scopus
Muñoz-Martínez, S, Sapena, V, Forner, A, Nault, J C, Sapisochin, G, Rimassa, L, Sangro, B, Bruix, J, Sanduzzi-Zamparelli, M, Hołówko, W, El Kassas, M, Mocan, T, Bouattour, M, Merle, P, Hoogwater, F J H, Alqahtani, S A, Reeves, H L, Pinato, D J, Giorgakis, E, Meyer, T, Villadsen, G E, Wege, H, Salati, M, Mínguez, B, Di Costanzo, G G, Roderburg, C, Tacke, F, Varela, M, Galle, P R, Alvares-da-Silva, M R, Trojan, J, Bridgewater, J, Cabibbo, G, Toso, C, Lachenmayer, A, Casadei-Gardini, A, Toyoda, H, Lüdde, T, Villani, R, Matilla Peña, A M, Guedes Leal, C R, Ronzoni, M, Delgado, M, Perelló, C, Pascual, S, Lledó, J L, Argemi, J, Basu, B, da Fonseca, L, Acevedo, J, Siebenhüner, A R, Braconi, C, Meyers, B M, Granito, A, Sala, M, Rodríguez-Lope, C, Blaise, L, Romero-Gómez, M, Piñero, F, Gomez, D, Mello, V, Pinheiro Alves, R C, França, A, Branco, F, Brandi, G, Pereira, G, Coll, S, Guarino, M, Benítez, C, Anders, M M, Bandi, J C, Vergara, M, Calvo, M, Peck-Radosavljevic, M, García-Juárez, I, Cardinale, V, Lozano, M, Gambato, M, Okolicsanyi, S, Morales-Arraez, D, Elvevi, A, Muñoz, A E, Lué, A, Iavarone, M & Reig, M 2021, ' Assessing the impact of COVID-19 on liver cancer management (CERO-19) ', JHEP Reports, vol. 3, no. 3, 100260 . https://doi.org/10.1016/j.jhepr.2021.100260
JHEP Reports
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Digital.CSIC. Repositorio Institucional del CSIC
Scientia

[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5d91fba7e4b287061ed941a9342414
http://hdl.handle.net/10261/266093